Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
1.080
-0.100 (-8.47%)
At close: Oct 29, 2024, 4:00 PM
1.090
+0.010 (0.93%)
After-hours: Oct 29, 2024, 7:55 PM EDT
Calidi Biotherapeutics Stock Forecast
CLDI's stock price has decreased by -95.4% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for CLDI stock have an average target of 16.67, with a low estimate of 10 and a high estimate of 20. The average target predicts an increase of 1,443.52% from the current stock price of 1.08.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 27, 2024.
Analyst Ratings
The average analyst rating for CLDI stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +825.93% | Jun 27, 2024 |
| Baird | Baird | Buy Maintains $45 → $20 | Buy | Maintains | $45 → $20 | +1,751.85% | May 15, 2024 |
| Baird | Baird | Buy Maintains $90 → $45 | Buy | Maintains | $90 → $45 | +4,066.67% | Mar 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $110 → $20 | Strong Buy | Maintains | $110 → $20 | +1,751.85% | Mar 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $110 | Strong Buy | Initiates | $110 | +10,085.19% | Nov 22, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.07
from -17.30
EPS Next Year
-1.82
from -5.07
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -3.93 | -0.81 | -0.53 |
| Avg | -5.07 | -1.82 | -1.73 |
| Low | -6.08 | -2.74 | -2.84 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.